Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target […]
Pulmonx (NASDAQ:LUNG – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.36) EPS for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.07, Zacks reports. Pulmonx had a negative net margin of 80.46% and a negative return on equity of 46.61%. The firm had revenue of $18.85 million for […]
Pulmonx (NASDAQ:LUNG – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.36) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.07, Zacks reports. Pulmonx had a negative return on equity of 46.61% and a negative net margin of 80.46%. The business had revenue of $18.85 […]
Pulmonx (NASDAQ:LUNG – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Wednesday, May 1st. Analysts expect Pulmonx to post earnings of ($0.43) per share for the quarter. Pulmonx has set its FY 2024 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do […]
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have received an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price among […]